Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis | Zendy

P Jambulingam | Zendy; S. Subramanian | Zendy; Kaliannagounder Krishnamoorthy | Zendy; Taniawati Supali | Zendy; Peter Fischer | Zendy; Christine Dubray | Zendy; Carl Fayette | Zendy; Jean Frantz Lemoine | Zendy; Moses Laman | Zendy; Christopher L. King | Zendy; Josaia Samuela | Zendy; Myra Hardy | Zendy; Gary J. Weil | Zendy

Open Access

Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis

Author(s) -

P Jambulingam,

S. Subramanian,

Kaliannagounder Krishnamoorthy,

Taniawati Supali,

Peter Fischer,

Christine Dubray,

Carl Fayette,

Jean Frantz Lemoine,

Moses Laman,

Christopher L. King,

Josaia Samuela,

Myra Hardy,

Gary J. Weil

Publication year - 2022

Publication title -

american journal of tropical medicine and hygiene

Language(s) - English

Resource type - Journals

eISSN - 1476-1645

pISSN - 0002-9637

DOI - 10.4269/ajtmh.21-0898

Subject(s) - lymphatic filariasis , diethylcarbamazine , mass drug administration , ivermectin , albendazole , tolerability , wuchereria bancrofti , medicine , neglected tropical diseases , anthelmintic , filariasis , environmental health , pharmacology , adverse effect , veterinary medicine , immunology , helminths , surgery , pathology , public health , population

This article is a compilation of summaries prepared by lead investigators for large-scale safety and efficacy studies on mass drug administration of IDA (ivermectin, diethylcarbamazine, and albendazole) for lymphatic filariasis. The summaries highlight the experiences of study teams that assessed the safety and efficacy of IDA in five countries: India, Indonesia, Haiti, Papua New Guinea, and Fiji. They also highlight significant challenges encountered during these community studies and responses to those challenges that contributed to success.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research